Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormone replacement therapy for internal risk patients].

Alfred O Mueck1

  • 1Schwerpunkt fur Endokrinologie und Menopause, Institut fur Frauengesundheit Baden-Wurttemberg, Universitats-Frauenklinik Tubingen, Tubingen, Deutschland. endo.meno@med.uni-tuebingen.de

Gynakologisch-Geburtshilfliche Rundschau
|October 28, 2006
PubMed
Summary

Hormone replacement therapy (HRT) requires careful risk assessment. Personalized HRT strategies, considering progestin choice and delivery, can minimize risks for women with severe symptoms and existing health conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The feasibility of ovarian tissue cryopreservation in selected females after hematopoietic stem cell transplantation.

Bone marrow transplantation·2026
Same author

A randomized controlled trial on the effect of Gushukang on bone mineral density in perimenopausal and postmenopausal women.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same author

Effect of orlistat and anti-androgen oral contraceptives on pregnancy outcomes in overweight or obese PCOS patients during comprehensive management.

Archives of gynecology and obstetrics·2026
Same author

Karyotype-based evaluation of ovarian reserve before ovarian tissue cryopreservation in Turner syndrome patients.

Journal of ovarian research·2026
Same author

Effects of a mutation in the transmembrane and coiled-coil domains 2 gene on ovarian function and reproductive aging.

Maturitas·2026
Same author

Practice guideline for the treatment and management of iatrogenic premature ovarian insufficiency.

Maturitas·2025

Area of Science:

  • Endocrinology
  • Gynecology
  • Cardiology

Background:

  • Hormone replacement therapy (HRT) necessitates consideration of contraindications, often based on group risk assumptions.
  • However, HRT may be beneficial for severe menopausal symptoms even with increased patient risk.

Purpose of the Study:

  • To provide practical recommendations for HRT use in patients with specific internal risk factors.
  • To detail risk stratification and management strategies for HRT.

Main Methods:

  • Review of existing data on HRT risks and benefits in various patient subgroups.
  • Focus on transdermal estradiol and neutral progestins for internal risk patients.
  • Analysis of risks like venous thrombosis, stroke, and myocardial infarction.

Related Experiment Videos

Main Results:

  • Transdermal HRT with specific progestins is preferred for patients with cardiovascular risks (diabetes, hypertension, dyslipidemia, smokers).
  • Thyroid, hepatobiliary diseases, porphyria, and lupus erythematosus are discussed as other risk factors.
  • Risk-benefit analysis guides HRT application in patients with severe complaints.

Conclusions:

  • Differentiated HRT preparation and application can minimize risks.
  • Transdermal routes and neutral progestins are recommended for high-risk individuals.
  • Individualized HRT decisions are crucial, balancing symptom relief with risk management.